| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2005;36:676.)
© 2005 American Heart Association, Inc.
Research Report |
From the Departments of Neurology (N.U.K., W.L.Y.), Radiology (A.J.M., D.A.S., R.T.H.), Anesthesia and Perioperative Care (W.L.Y.), Neurological Surgery (R.T.H., W.L.Y.), and Center for Cerebrovascular Research (A.S.A., M.C., D.A.S., W.L.Y.), University of California, San Francisco; and Philips Medical Systems (A.J.M.), Cleveland, Ohio.
Correspondence to William L. Young, MD, UCSF, 1001 Potrero Ave, Room 3C-38, San Francisco, CA 94110. E-mail ccr{at}anesthesia.ucsf.edu
| Abstract |
|---|
|
|
|---|
Methods Eight patients with high-grade carotid stenoses underwent bolus-tracking MR perfusion and intra-arterial 133Xe washout before and after carotid stenting. MR perfusion was compared with 133Xe-CBF values using Pearson linear correlation analysis.
Results We observed a mean 37±38% increase in 133Xe-CBF and a mean 19±27% increase in relative CBF (rCBF) by MR perfusion immediately after stent placement. Relative (percent) changes in MR-rCBF showed a close and linear correlation to those seen in 133Xe-CBF (r=0.91; R2=0.84; P=0.002). There was a trend for MR perfusion to underestimate change in CBF at higher relative changes in flow.
Conclusion Bolus-tracking MR perfusion correlates with 133Xe-CBF in estimating postprocedural increases in blood flow but may underestimate the magnitude of the change with higher relative changes.
Key Words: cerebral blood flow magnetic resonance imaging xenon
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
All procedures were performed in a combined "XMR" suite consisting of a 1.5T MR scanner (Philips Integra) and an integrated catheterization laboratory (Philips Integris V5000) connected via a floating tabletop, permitting rapid patient transfer between the 2 systems.
Endovascular Technique
A transfemoral approach under intravenous sedation was used in all cases with selective catheterization of the target artery as described previously.3 Systemic anticoagulation using intravenous heparin (70 U/kg) was continued for 12 hours. The stent device (Smart Stent, Precise Stent, or Mednova Carotid Stent; Abbott Laboratories) was selected on the basis of the anatomical location and diameter of the artery. No distal protection devices were used. Percutaneous suture ligation of the arteriotomy site was performed using the Perclose device (Abbott Laboratories).
Each patient was closely monitored for 24 hours after the procedure. In general, intravenous labetalol or nicardipine was used to maintain systolic blood pressures
160 mm Hg and diastolic blood pressure
100 mm Hg. Each patient was treated with daily aspirin (325 mg) and clopidogrel (75 mg; Plavix; Bristol-Myers Squibb/Sanofi Pharmaceuticals) starting 3 days before the procedure.
CBF Measurements
133Xe-CBF
These data were taken from a larger study of the physiological effects of endovascular stenting in intracranial and extracranial vessels.4 CBF was determined by the intra-arterial 133Xe injection initial slope method as described previously.5
MR Indices of Perfusion
These data were taken from a larger study of the diagnostic accuracy of MR perfusion. MR acquisitions included angiography, phase-contrast quantitative flow, and single-shot T2* perfusion as described previously.6 T1-shortening gadolinium-based contrast (Omniscan; Amersham Health) was administered intravenously. Perfusion data were fit to a standard gamma variate function, and relative CBF (rCBF) and relative cerebral blood volume (rCBV) parameters were extracted.7,8 MRI regions of interest were selected to best approximate the field of view of the external 133Xe detectors, providing a more direct comparison between the 2 modalities (Figure 1).
|
Data Analysis
Descriptive statistics are expressed as mean±SD. Results were analyzed by Pearson linear correlation, linear regression, and ANOVA. In addition, we subjected the data for relative changes in CBF to analysis described by Bland and Altman9 and previously reported when comparing perfusion indices against the 133Xe gold standard.5
| Results |
|---|
|
|
|---|
|
133Xe-CBF measured immediately before and after stent placement (mean 48±17 minutes) showed a mean 37±38% increase. Bolus tracking MR perfusion measured within 1 hour demonstrated a mean 19±27% increase in rCBF (Table). Changes observed by the 2 modalities showed close and linear correlations (Figure 2A through 2F).
|
We calculated the "limits of agreement" between the relative changes determined by MR measurements and by 133Xe-CBF method (Figure 2G through 2I). There was a trend for MRI to underestimate the extent of perfusion increase at higher degrees of change.
Observed correlations were not significantly affected by adjusting for physiological parameters, type of anesthesia, time between measurements, and patient characteristics. There were no differences between symptomatic and asymptomatic patients.
| Discussion |
|---|
|
|
|---|
Because of the spatial limitation of the radioactive tracer technique, we only examined ipsilateral CBF correlations. MRI has the ability to assess perfusion changes in the contralateral hemisphere. Further studies will be necessary to compare CBF changes in other brain regions. Use of bolus-tracking MR perfusion data may improve selection of patients who may benefit from procedures such as stenting. These methods can accurately demonstrate acute hemodynamic effects of interventional revascularization techniques.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received August 26, 2004; revision received October 8, 2004; accepted October 8, 2004.
| References |
|---|
|
|
|---|
2. North American Symptomatic Carotid Endarterectomy Trial Collaborators Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991; 325: 445453.[Abstract]
3. Meyers PM, Higashida RT, Phatouros CC, Malek AM, Lempert TE, Dowd CF, Halbach VV. Cerebral hyperperfusion syndrome after percutaneous transluminal stenting of the craniocervical arteries. Neurosurgery. 2000; 47: 335343.[CrossRef][Medline] [Order article via Infotrieve]
4. Ko NU, Achrol AS, Gupta DK, Chopra M, Sahu M, Smith WS, Higashida RT, Young WL. Cerebral blood flow changes after endovascular treatment of cerebrovascular stenoses. AJNR Am J Neuroradiol. 2005;26. In press.
5. Young WL, Prohovnik I, Schroeder T, Correll JW, Ostapkovich ND. Intraoperative 133Xe cerebral blood flow measurements by intravenous versus intracarotid methods. Anesthesiology. 1990; 73: 637643.[Medline] [Order article via Infotrieve]
6. Martin AJ, Saloner DA, L. RTP, Roberts H, Weber OM, Dillon WP, Cullen S, Halbach VV, Dowd CF, Higashida RT. Carotid stent delivery in an XMR suite: immediate assessment of the physiologic impact of extracranial revascularization. AJNR Am J Neuroradiol. 2005;26. In press.
7. Edelman RR, Mattle HP, Atkinson DJ, Hill T, Finn JP, Mayman C, Ronthal M, Hoogewoud HM, Kleefield J. Cerebral blood flow: assessment with dynamic contrast-enhanced T2*-weighted MR imaging at 1.5-T1. Radiology. 1990; 176: 211220.
8. Rosen BR, Belliveau JW, Chien D. Perfusion imaging by nuclear magnetic resonance. Magn Reson Q. 1989; 5: 263281.[Medline] [Order article via Infotrieve]
9. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986; 1: 307310.[CrossRef][Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
J-M Olivot, M. Mlynash, G. Zaharchuk, M. Straka, R. Bammer, N. Schwartz, M. G. Lansberg, M. E. Moseley, and G. W. Albers Perfusion MRI (Tmax and MTT) correlation with xenon CT cerebral blood flow in stroke patients Neurology, March 31, 2009; 72(13): 1140 - 1145. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Haller, L. H. Bonati, J. Rick, M. Klarhofer, O. Speck, P. A. Lyrer, D. Bilecen, S. T. Engelter, and S. G. Wetzel Reduced Cerebrovascular Reserve at CO2 BOLD MR Imaging Is Associated with Increased Risk of Periinterventional Ischemic Lesions during Carotid Endarterectomy or Stent Placement: Preliminary Results Radiology, October 1, 2008; 249(1): 251 - 258. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |